Cargando…
Emerging molecular targets and therapy for cholangiocarcinoma
Cholangiocarcinoma (CCA) is a rare cancer arising from the biliary tree with a poor prognosis and limited therapeutic options. Recent large scale molecular characterisation studies have identified recurrent genetic alterations in CCA which may be amenable to therapeutic targeting. In this review we...
Autores principales: | Kayhanian, Hamzeh, Smyth, Elizabeth C, Braconi, Chiara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534395/ https://www.ncbi.nlm.nih.gov/pubmed/28808500 http://dx.doi.org/10.4251/wjgo.v9.i7.268 |
Ejemplares similares
-
Targeting the IL-6 Dependent Phenotype Can Identify Novel Therapies for Cholangiocarcinoma
por: Braconi, Chiara, et al.
Publicado: (2010) -
Cholangiocarcinoma Disease Modelling Through Patients Derived Organoids
por: Amato, Francesco, et al.
Publicado: (2020) -
Heterogeneity of Cholangiocarcinoma Immune Biology
por: Vita, Francesca, et al.
Publicado: (2023) -
The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets
por: Chong, Dawn Q., et al.
Publicado: (2016) -
Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials
por: Simile, Maria Maddalena, et al.
Publicado: (2019)